5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[3,2,1-jk]carbazole

Catalog No. :
ACEWUI257
CAS No. :
1454807-26-1
Molecular Formula :
C24H22BNO2
Molecular Weight :
367.26

IUPAC Name:5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[3,2,1-jk]carbazole

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[3,2,1-jk]carbazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[3,2,1-jk]carbazole
IUPAC Name5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[3,2,1-jk]carbazole
Molecular FormulaC24H22BNO2
Molecular Weight367.26
SMILESCC1(C)C(C)(C)OB(C2=CC3=C(N4C5=C(C6=C4C3=CC=C6)C=CC=C5)C=C2)O1
InChI KeyARDAOPBRXDNRCA-UHFFFAOYSA-N
SynonymIndolo[3,2,1-jk]carbazole, 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolo[3,2,1-jk]carbazole
CAS No.1454807-26-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEWUI257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQKNU951 route compound structure diagram
    ACQKNU951109589-98-2 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACEWUI257 route product structure diagram
    ACEWUI2571454807-26-1
Inquiry

2. ACEWUI257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEWUI257 route product structure diagram
    ACEWUI2571454807-26-1
Inquiry

Comments (0)